Concepedia

Emilie A. Chapeau

EA

8

Publications

606

Citations

8

H-Index

2004

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Emilie A. Chapeau is an author at Novartis (Switzerland) specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2004–2024

8

Publications

8

Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism

Eric Erquan Zhang, Emilie A. Chapeau, Kazuki Hagihara et al. · Proceedings of the National Academy of Sciences · 2004 · 258 citations · Full text

Direct and selective pharmacological disruption of the YAP–TEAD interface by IAG933 inhibits Hippo-dependent and RAS–MAPK-altered cancers

Emilie A. Chapeau, Laurent Sansregret, Giorgio Giacomo Galli et al. · Nature Cancer · 2024 · 104 citations · Full text

Dose and Schedule Determine Distinct Molecular Mechanisms Underlying the Efficacy of the p53–MDM2 Inhibitor HDM201

Sébastien Jeay, Stéphane Ferretti, Philipp Holzer et al. · Cancer Research · 2018 · 85 citations · Full text

Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf <sup>−/−</sup> mouse model

Emilie A. Chapeau, Agnieszka Gembarska, Éric Durand et al. · Proceedings of the National Academy of Sciences · 2017 · 61 citations · Full text

The First Class of Small Molecules Potently Disrupting the YAP‐TEAD Interaction by Direct Competition

Pascal Furet, Vincent Bordas, Mickaël Le Douget et al. · ChemMedChem · 2022 · 42 citations

, , +16

Rows per page

1–5 of 8